Are testosterone side effects in women permanent?
Most aren't. Acne, hair growth where you apply the cream, and weight change typically improve when the dose comes down or stops. Facial hair and scalp thinning usually improve more slowly. The exceptions are voice deepening and clitoral enlargement, which may not fully reverse — and reliable reversibility data for those doesn't exist. Neither appeared in randomized trials of physiological-dose transdermal testosterone covering 3,035 women. They're associated with getting more testosterone than a woman's body normally makes.
How long do testosterone side effects take to go away?
That depends entirely on your delivery route. With a cream or gel, your exposure ends when you stop applying it — though the tissue changes it caused take their own time to settle. With a pellet, you wait, because it keeps releasing for three to six months and cannot be removed or turned down. That gap — same drug, days versus months — is the single biggest practical difference between the routes.
Does testosterone cause facial hair in women?
It can, and it's one of the two most common effects. In pooled randomized data across 8,480 women, testosterone raised the likelihood of hair growth with a relative risk of 1.69 versus placebo — roughly 3 to 5 extra cases per 100 women. In transdermal-only trials the figure was lower. If hair appears at the spot where you apply the cream, rotating your application site often solves it. If it's appearing on your face, that generally signals the dose is too high and is worth a call.
Can testosterone cause hair loss on my head?
Randomized trials of physiological-dose transdermal testosterone in 3,035 women found no evidence of alopecia — scalp thinning did not increase compared with placebo. At supraphysiological levels, androgenic alopecia is a recognized consequence of androgen excess. New or rapid scalp thinning on testosterone suggests your level has gone above the female range and should be checked. Midlife hair loss also has plenty of other causes worth ruling out.
Will testosterone deepen my voice?
Voice deepening did not appear in randomized trials of physiological-dose transdermal testosterone in women, and both the British Menopause Society and the Global Consensus Position Statement describe it as rare at physiological replacement levels. It's associated with supraphysiological exposure. One prospective pellet cohort reported temporary hoarseness in about 1% of women. A new, persistent voice change while on testosterone warrants a prompt call — it may not reverse, and that's the reason to act early rather than wait.
Can testosterone cause clitoral enlargement?
It did not appear in randomized trials at physiological doses, and the largest prospective pellet cohort reported zero cases. It's associated with getting more testosterone than a woman's body normally produces. Like voice change, it may not fully reverse, so a new change is a reason to contact your prescriber rather than monitor it yourself. This is one of the two effects that make the delivery route decision matter more than any other choice on this page.
Does testosterone cause weight gain in women?
Pooled randomized data did record an overall weight increase with testosterone, and the British Menopause Society lists weight gain among the common, usually reversible effects. But the available sources don't establish a reliable rate or an expected amount. Weight in midlife changes for many overlapping reasons. Track when the change started relative to your dose, and review the whole picture with your clinician.
Does testosterone increase breast cancer risk in women?
Short-term transdermal testosterone does not appear to affect breast cancer risk and does not increase mammographic breast density — both Level I, Grade A findings. However, randomized data are insufficient to assess long-term risk, and women with prior breast cancer were excluded from the trials. Caution is recommended for anyone with hormone-sensitive breast cancer, and that's a specialist conversation. There's no evidence supporting testosterone to prevent breast cancer, despite some observational registries reporting lower-than-expected rates.
Can testosterone raise my blood pressure?
Two things are true at once. In February 2025 the FDA added a blood pressure warning to all testosterone product labels after monitoring studies confirmed increases across the class — but those studies were in men, at male doses. In women, the Global Consensus found testosterone at physiological doses was not associated with increases in blood pressure, blood glucose, or HbA1c (Level I, Grade A). The male label warning is real. It hasn't been measured at a female dose, which is roughly one-tenth as much.
Do I need blood tests while taking testosterone?
Yes, and this is one of the strongest points of agreement across guidelines. You should have a total testosterone level drawn before starting, another 3 to 6 weeks after starting or after any dose increase, and then periodically — every 4 to 6 months per ISSWSH, every 6 to 12 months per the British Menopause Society. The purpose isn't to hit a target number; it's to make sure you're not getting more than a woman's body normally makes. If nobody drew a baseline, that tells you something about the prescriber.
Why do I have side effects when my testosterone level is normal?
Usually SHBG — sex hormone-binding globulin, the protein that binds most of your testosterone and holds it inactive. Only about 1 to 3% of your testosterone circulates free and does the work. If your SHBG is low, more of it is active, so your total level can read perfectly normal while you experience androgenic effects anyway. Both the ISSWSH guideline and the British Menopause Society describe this. Low SHBG is associated with type 2 diabetes, metabolic syndrome, and obesity. Ask for it to be measured.
Are testosterone pellets safe for women?
The Global Consensus Position Statement recommends against any preparation producing supraphysiological levels, specifically naming pellets and injections, and guidelines endorsed by 12 major medical organizations recommend against hormone pellets. Published pellet studies report mean levels of 144 to 299 ng/dL against a normal female ceiling near 55 ng/dL. The core problem isn't the peak — it's that a pellet can't be removed or dialed down for three to six months. Safety data are almost entirely observational, from a small number of practices, several with financial conflicts.
Can I take DHEA instead of testosterone?
Not for low desire. The Global Consensus concluded systemic DHEA is not associated with significant improvement in libido or sexual function in postmenopausal women with normal adrenal function and cannot be recommended for HSDD — Level IA, Grade A, its highest grade. The ISSWSH guideline reaches the same conclusion, and the British Menopause Society says more research is needed. Vaginal DHEA (prasterone) is different: it's FDA-approved for painful sex due to menopause, which is a separate problem.
Is testosterone FDA-approved for women?
No. There has never been an FDA-approved testosterone product for women in the United States. The FDA declined the Intrinsa patch in December 2004 despite it demonstrating efficacy over placebo, and BioSante's LibiGel missed its efficacy endpoints in 2011. Every American woman on testosterone is using a male-approved product off-label at roughly one-tenth the male dose, or a compounded preparation. Australia registered AndroFeme 1 in November 2020; it's now also licensed in New Zealand and South Africa. Verified July 2026.
Is compounded testosterone the same as FDA-approved testosterone?
No. They are different regulatory categories and should never be described as equivalent. Compounded products are not FDA-approved and are not subject to the same manufacturing inspection as approved products, and studies have documented variability in the actual testosterone concentration of compounded preparations. The ISSWSH guideline says compounded products cannot be recommended. The Global Consensus permits them only where no approved equivalent exists — which is the US situation — provided the pharmacy meets ingredient purity and Good Manufacturing Practice standards.
Is testosterone a controlled substance?
Yes. Testosterone is a Schedule III controlled substance in the United States. It requires a prescription from a licensed clinician, and prescribers can only issue limited quantities at a time, which means repeat visits to refill. Telehealth rules for controlled substances differ from those for estrogen or progesterone, so availability varies by provider and by state. There is no legitimate way to obtain it without a prescription.
How long until testosterone works?
Reductions in distress about low desire tend to appear around four weeks, with average efficacy emerging at six to eight weeks and maximum effect on desire and satisfying sexual events at about twelve weeks. Distress continues to decline over the following five to six months. If you haven't experienced meaningful improvement by six months, guidelines say to stop rather than increase the dose, and to re-investigate the cause. If it is working, the ISSWSH panel suggests considering a break at 6 to 12 months to see whether you still need it.
Should I stop testosterone if I get a side effect?
Don't change or stop a prescription based on a website — including this one. What you should do is write down what the symptom is, when it started, and what changed just before it, then contact your prescriber. Some symptoms warrant a prompt call rather than waiting for your next appointment: a new or persistent voice change, rapid scalp thinning, clitoral enlargement, or several androgenic changes appearing together. Emergency symptoms — chest pain, sudden shortness of breath, one-sided weakness, difficulty speaking — mean emergency care, now.
Is this the same as gender-affirming testosterone?
No. The population, the goals, the doses, and the expected physical effects are all different. Gender-affirming testosterone aims for a different hormonal range entirely, and many of the effects treated as side effects on this page are intended outcomes there. Nothing on this page should be read as guidance for gender-affirming care, and applying menopause-dose research to it — or the reverse — produces wrong answers in both directions. Please seek a specialist source.
